These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of existing guidelines for their adequacy for the molecular characterisation and environmental risk assessment of genetically modified plants obtained through synthetic biology. ; Naegeli H; Bresson JL; Dalmay T; Dewhurst IC; Epstein MM; Firbank LG; Guerche P; Hejatko J; Moreno FJ; Nogue F; Rostoks N; Sanchez Serrano JJ; Savoini G; Veromann E; Veronesi F; Casacuberta J; De Schrijver A; Messean A; Patron N; Zurbriggen M; Alvarez F; Devos Y; Gennaro A; Streissl F; Papadopoulou N; Mullins E EFSA J; 2021 Feb; 19(2):e06301. PubMed ID: 33598046 [TBL] [Abstract][Full Text] [Related]
3. Potential use of gene drive modified insects against disease vectors, agricultural pests and invasive species poses new challenges for risk assessment. Devos Y; Mumford JD; Bonsall MB; Camargo AM; Firbank LG; Glandorf DCM; Nogué F; Paraskevopoulos K; Wimmer EA Crit Rev Biotechnol; 2022 Mar; 42(2):254-270. PubMed ID: 34167401 [TBL] [Abstract][Full Text] [Related]
4. EFSA's scientific activities and achievements on the risk assessment of genetically modified organisms (GMOs) during its first decade of existence: looking back and ahead. Devos Y; Aguilera J; Diveki Z; Gomes A; Liu Y; Paoletti C; du Jardin P; Herman L; Perry JN; Waigmann E Transgenic Res; 2014 Feb; 23(1):1-25. PubMed ID: 23963741 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of existing guidelines for their adequacy for the food and feed risk assessment of genetically modified plants obtained through synthetic biology. ; Mullins E; Bresson JL; Dalmay T; Dewhurst IC; Epstein MM; Firbank LG; Guerche P; Hejatko J; Moreno FJ; Nogue F; Rostoks N; Sanchez Serrano JJ; Savoini G; Veromann E; Veronesi F; Casacuberta J; Zurbriggen MD; Fernandez A; Gomez Ruiz JA; Gennaro A; Papadopoulou N; Lanzoni A; Naegeli H EFSA J; 2022 Jul; 20(7):e07410. PubMed ID: 35873722 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of existing guidelines for their adequacy for the microbial characterisation and environmental risk assessment of microorganisms obtained through synthetic biology. ; More S; Bampidis V; Benford D; Bragard C; Halldorsson T; Hernández-Jerez A; Susanne HB; Koutsoumanis K; Machera K; Naegeli H; Nielsen SS; Schlatter J; Schrenk D; Silano V; Turck D; Younes M; Glandorf B; Herman L; Tebbe C; Vlak J; Aguilera J; Schoonjans R; Cocconcelli PS EFSA J; 2020 Oct; 18(10):e06263. PubMed ID: 33144886 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of existing guidelines for their adequacy for the food and feed risk assessment of microorganisms obtained through synthetic biology. ; More S; Bampidis V; Benford D; Bragard C; Halldorsson T; Hernández-Jerez A; Bennekou SH; Koutsoumanis K; Lambré C; Machera K; Mullins E; Nielsen SS; Schlatter J; Schrenk D; Turck D; Younes M; Herman L; Pelaez C; van Loveren H; Vlak J; Revez J; Aguilera J; Schoonjans R; Cocconcelli PS EFSA J; 2022 Aug; 20(8):e07479. PubMed ID: 35991959 [TBL] [Abstract][Full Text] [Related]
9. Annual post-market environmental monitoring (PMEM) report on the cultivation of genetically modified maize MON 810 in 2015 from Monsanto Europe S.A. ; Naegeli H; Birch AN; Casacuberta J; De Schrijver A; Gralak MA; Guerche P; Jones H; Manachini B; Messéan A; Nielsen EE; Nogué F; Robaglia C; Rostoks N; Sweet J; Tebbe C; Visioli F; Wal JM; Álvarez F; Ardizzone M; Devos Y; Fernández-Dumont A EFSA J; 2017 May; 15(5):e04805. PubMed ID: 32625494 [TBL] [Abstract][Full Text] [Related]
10. Applicability of the EFSA Opinion on site-directed nucleases type 3 for the safety assessment of plants developed using site-directed nucleases type 1 and 2 and oligonucleotide-directed mutagenesis. ; Naegeli H; Bresson JL; Dalmay T; Dewhurst IC; Epstein MM; Firbank LG; Guerche P; Hejatko J; Moreno FJ; Mullins E; Nogué F; Sánchez Serrano JJ; Savoini G; Veromann E; Veronesi F; Casacuberta J; Gennaro A; Paraskevopoulos K; Raffaello T; Rostoks N EFSA J; 2020 Nov; 18(11):e06299. PubMed ID: 33281977 [TBL] [Abstract][Full Text] [Related]
11. Risk Assessment Considerations for Genetically Modified RNAi Plants: EFSA's Activities and Perspective. Papadopoulou N; Devos Y; Álvarez-Alfageme F; Lanzoni A; Waigmann E Front Plant Sci; 2020; 11():445. PubMed ID: 32373145 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the 2017 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810. ; Álvarez F; Camargo AM; Devos Y EFSA J; 2019 Jun; 17(6):e05742. PubMed ID: 32626360 [TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal Controllability and Environmental Risk Assessment of Genetically Engineered Gene Drive Organisms from the Perspective of European Union Genetically Modified Organism Regulation. Then C; Kawall K; Valenzuela N Integr Environ Assess Manag; 2020 Sep; 16(5):555-568. PubMed ID: 32250054 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the 2020 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU. ; Álvarez F; Martín Camargo A; Messéan A; Lenzi P; Streissl F EFSA J; 2022 Jul; 20(7):e07406. PubMed ID: 35814921 [TBL] [Abstract][Full Text] [Related]
15. Annual post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in 2016. ; Álvarez F; Devos Y; Georgiadis M; Messéan A; Waigmann E EFSA J; 2018 May; 16(5):e05287. PubMed ID: 32625921 [TBL] [Abstract][Full Text] [Related]
16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
17. Principles for the risk assessment of genetically modified microorganisms and their food products in the European Union. Aguilera J; Gomes AR; Olaru I Int J Food Microbiol; 2013 Oct; 167(1):2-7. PubMed ID: 23632210 [TBL] [Abstract][Full Text] [Related]
18. Statement complementing the EFSA Scientific Opinion on application (EFSA-GMO-NL-2009-75) for placing on the market of genetically modified oilseed rape Ms8 × Rf3 × GT73 and subcombinations, which have not been authorised previously (i.e. Ms8 × GT73 and Rf3 × GT73) independently of their origin, for food and feed uses, import and processing, with the exception of isolated seed protein for food, under Regulation (EC) No 1829/2003), taking into consideration additional information. ; Naegeli H; Bresson JL; Dalmay T; Dewhurst IC; Epstein MM; Firbank LG; Guerche P; Hejatko J; Moreno FJ; Mullins E; Nogué F; Rostoks N; Sánchez Serrano JJ; Savoini G; Veromann E; Veronesi F; Ardizzone M; Lanzoni A; Paraskevopoulos K EFSA J; 2020 Jul; 18(7):e06200. PubMed ID: 32742436 [TBL] [Abstract][Full Text] [Related]
19. Gene drives in our future: challenges of and opportunities for using a self-sustaining technology in pest and vector management. Collins JP BMC Proc; 2018; 12(Suppl 8):9. PubMed ID: 30079101 [TBL] [Abstract][Full Text] [Related]